Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:44 PM
Ignite Modification Date:
2025-12-24 @ 4:44 PM
NCT ID:
NCT05054166
Eligibility Criteria:
Inclusion Criteria:
1. Patients with HER2- metastatic breast cancer
2. Patients with PI3K/AKT/mTOR mutation
Exclusion Criteria:
1. Patients treated with endocrinotherapy and everolimus.
2. The efficacy evaluation could not be available.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
29 Years
Maximum Age:
66 Years
Study:
NCT05054166
Study Brief:
Protocol Section:
NCT05054166